Cardiff Oncology (CRDF) Restructuring Costs (2016 - 2018)

Cardiff Oncology has reported Restructuring Costs for 3 years, with the latest figure at $421351.0 in Q3 2018.

• Quarterly Restructuring Costs rose 1006.68% year-over-year to $421351.0 in Q3 2018, while the trailing twelve-month figure through Sep 2019 was $421351.0 (down 63.0% YoY) and the FY2018 annual result came in at $664686.0, down 69.43% from the prior year.
• Restructuring Costs rose to $421351.0 in Q3 2018 per CRDF's latest filing, from $243335.0 in the prior quarter.
• Over five years, Restructuring Costs peaked at $1.7 million in Q1 2017 and troughed at -$46472.0 in Q3 2017.
• A 3-year average of $514128.7 and a median of $421351.0 in 2018 frame the typical range for Restructuring Costs.
• The sharpest annual moves came in 2017 and 2018: Restructuring Costs slumped 40.0% in 2017, then jumped 6493.46% in 2018.
• Over 3 years, Restructuring Costs stood at $790438.0 in 2016, then plunged by 40.0% to $474251.0 in 2017, then slipped by 11.15% to $421351.0 in 2018.
• According to Business Quant data, Restructuring Costs over the past three periods registered $421351.0, $243335.0, and $474251.0 for Q3 2018, Q2 2018, and Q4 2017 respectively.